Abiopharma

New Form 8-K - Werewolf Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140727 Size: 315 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits